What is Myriad Genetics's net investment in lease?

Myriad Genetics (MYGN) reported net investment in lease of $51M in Q1 2026.

How has Myriad Genetics's net investment in lease changed year-over-year?

Myriad Genetics's net investment in lease decreased by 4.5% year-over-year, from $53.4M to $51M.

What is the long-term trend for Myriad Genetics's net investment in lease?

Over 5 years (2020 to 2025), Myriad Genetics's net investment in lease has grown at a -3.7% compound annual growth rate (CAGR), from $59.7M to $49.4M.

Myriad Genetics MYGN Net Investment in Lease

Net Investment in Lease at other companies

Quest DiagnosticsDGX

——

NeoGenomicsNEO

——

VeracyteVCYT

——

Guardant HealthGH

——

Natera, Inc.NTRA

——

Tempus AI, Inc.TEM

——

Segments

By geography

See full

West Salt Lake City$2.7M—

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's net investment in lease?: Myriad Genetics (MYGN) reported net investment in lease of $51M in Q1 2026.
How has Myriad Genetics's net investment in lease changed year-over-year?: Myriad Genetics's net investment in lease decreased by 4.5% year-over-year, from $53.4M to $51M.
What is the long-term trend for Myriad Genetics's net investment in lease?: Over 5 years (2020 to 2025), Myriad Genetics's net investment in lease has grown at a -3.7% compound annual growth rate (CAGR), from $59.7M to $49.4M.